BLOOD PRODUCTS ADVISORY COMMITTEE March 15, 2002

3/13/02


Click here to start


Table of Contents

BLOOD PRODUCTS ADVISORY COMMITTEE March 15, 2002

Introduction and Background

ISSUE

Discussion at BPAC

Current FDA Regulations 21 CFR, part 1270

Subpart C-Procedures/Records 1270.31 Written Procedures

Current regulations, cont.

Future FDA Regulations (proposed, but not finalized)

GTP Proposed Requirements that may impact current events

GTP, cont.

GTP, cont.

GTP, cont.

GTP, cont.

GTP, cont.

GTP, cont.

Charge to the Committee

Charge, cont.

Author: solomonr